Trending...
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 136
- PandaGuarantee Launches Rent Guarantor Service in New York City
- J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
CHICAGO, Aug. 1, 2024 ~ The Association for Diagnostics & Laboratory Medicine (ADLM) welcomed a record-breaking number of laboratory experts to their annual meeting, ADLM 2024, from July 28 to August 1. Formerly known as the AACC Annual Scientific Meeting & Clinical Lab Expo, this year's event showcased groundbreaking advancements in diagnostic research and technology, highlighting the crucial role that laboratory medicine plays in patient care.
According to ADLM, as of Thursday, August 1, over 18,000 laboratory medicine professionals had registered for the meeting. This marks a significant increase of 6% in attendance since the last time the ADLM Annual Meeting was held in Chicago in 2022. With one more day left in the meeting, even more attendees are expected to join.
One of the highlights of the event was a special session featuring representatives from ADLM, the American Medical Association, and the Children's Hospital Association. They discussed how the FDA's final rule placing laboratory developed tests under FDA oversight will have a negative impact on patient care. The session also included a caregiver and patient advocate who shared their perspective on why these tests are essential for timely diagnoses and treatment.
More on illi News
Attendees were also treated to five plenary talks led by pioneers in life sciences. In the opening plenary, Dr. Patrick Bossuyt received the prestigious Wallace H. Coulter Lectureship award and spoke about his experiences leading efforts to improve diagnostic tests. He made a compelling case for why strong clinical trials of laboratory tests are necessary.
On Monday, Dr. Kojo S.J. Elenitoba-Johnson from Memorial Sloan Kettering Cancer Center discussed how proteomic data can help healthcare professionals better understand lymphomas and develop precision oncology therapies.
Tuesday's plenary speaker was Dr. Ron H.N. van Schaik from Erasmus MC - University Medical Center Rotterdam who talked about implementing pharmacogenetics as a diagnostic tool in routine healthcare. He shared both the successes and challenges of this approach.
On Wednesday, Dr. Sharon Hillier from the University of Pittsburgh explored the development of new products for HIV prevention, including those that can be used on demand and minimize exposure to antiretroviral drugs.
The closing keynote speaker, Dr. Diana Greene Foster from the University of California, San Francisco, discussed the mental health, physical health, and socioeconomic consequences faced by individuals who are unable to get an abortion.
More on illi News
As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could improve accurate diagnoses for more patients. The winner was Mercy BioAnalytics with their liquid biopsy platform that detects ovarian cancer in its earliest stages by measuring tumor-derived extracellular vesicles.
The ADLM 2024 Clinical Lab Expo featured nearly 900 exhibitors and covered an impressive 271,003 net square feet. This marks a 5% increase in exhibit space since the last time the meeting was held in Chicago. The expo showcased cutting-edge tests from all laboratory medicine disciplines, including artificial intelligence, molecular diagnostics, automation, point-of-care testing, mass spectrometry, mobile health, and more.
ADLM CEO Mark J. Golden expressed his excitement about the increased attendance at ADLM 2024 after the challenges faced during the COVID-19 pandemic. He also acknowledged that this has been a challenging year for laboratory medicine professionals with the FDA's final rule on laboratory developed tests. The meeting provided a crucial opportunity for attendees to learn more about what this rule means for their labs and patient care. Golden hopes that attendees will return home inspired and eager to implement what they've learned at this year's meeting in their work. He also looks forward to seeing what next year's meeting in Chicago from July 27-31 will bring.
In conclusion, ADLM 2024 was a resounding success with record-breaking attendance and groundbreaking advancements in diagnostic research and technology. The meeting provided a vital platform for laboratory medicine professionals to learn, network, and stay updated on the latest developments in their field.
According to ADLM, as of Thursday, August 1, over 18,000 laboratory medicine professionals had registered for the meeting. This marks a significant increase of 6% in attendance since the last time the ADLM Annual Meeting was held in Chicago in 2022. With one more day left in the meeting, even more attendees are expected to join.
One of the highlights of the event was a special session featuring representatives from ADLM, the American Medical Association, and the Children's Hospital Association. They discussed how the FDA's final rule placing laboratory developed tests under FDA oversight will have a negative impact on patient care. The session also included a caregiver and patient advocate who shared their perspective on why these tests are essential for timely diagnoses and treatment.
More on illi News
- BrainFunHub Launches Free, Fun Brain Games for Seniors, Families, and Caregivers
- UK Financial Ltd Confirms CATEX Exchange Integration of SMPRA and LTNS 1 Ahead of Compliance-Based Trading Activation
- Ashikaga Flower Park's "Great Wisteria Festival 2026"
- Chicago Travel Advisor Helps Midwest Families Plan Europe Trips That Actually Work
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
Attendees were also treated to five plenary talks led by pioneers in life sciences. In the opening plenary, Dr. Patrick Bossuyt received the prestigious Wallace H. Coulter Lectureship award and spoke about his experiences leading efforts to improve diagnostic tests. He made a compelling case for why strong clinical trials of laboratory tests are necessary.
On Monday, Dr. Kojo S.J. Elenitoba-Johnson from Memorial Sloan Kettering Cancer Center discussed how proteomic data can help healthcare professionals better understand lymphomas and develop precision oncology therapies.
Tuesday's plenary speaker was Dr. Ron H.N. van Schaik from Erasmus MC - University Medical Center Rotterdam who talked about implementing pharmacogenetics as a diagnostic tool in routine healthcare. He shared both the successes and challenges of this approach.
On Wednesday, Dr. Sharon Hillier from the University of Pittsburgh explored the development of new products for HIV prevention, including those that can be used on demand and minimize exposure to antiretroviral drugs.
The closing keynote speaker, Dr. Diana Greene Foster from the University of California, San Francisco, discussed the mental health, physical health, and socioeconomic consequences faced by individuals who are unable to get an abortion.
More on illi News
- Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
- New Research Identifies "The Busy Effect": 89% of Americans Want a Laid-Back Vacation — Only 15% Actually Achieve It
- Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
- Best Spiritual Healing, Meditation & Retreats in Sedona — Rise Meditation Helps You Find and Book Transformational Experiences
- $16 Billion Market by 2034 in Underwater Drones Presents Huge Opportunity for AI-Powered Autonomous Vehicle Serving Defense & Commercial Customers
As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could improve accurate diagnoses for more patients. The winner was Mercy BioAnalytics with their liquid biopsy platform that detects ovarian cancer in its earliest stages by measuring tumor-derived extracellular vesicles.
The ADLM 2024 Clinical Lab Expo featured nearly 900 exhibitors and covered an impressive 271,003 net square feet. This marks a 5% increase in exhibit space since the last time the meeting was held in Chicago. The expo showcased cutting-edge tests from all laboratory medicine disciplines, including artificial intelligence, molecular diagnostics, automation, point-of-care testing, mass spectrometry, mobile health, and more.
ADLM CEO Mark J. Golden expressed his excitement about the increased attendance at ADLM 2024 after the challenges faced during the COVID-19 pandemic. He also acknowledged that this has been a challenging year for laboratory medicine professionals with the FDA's final rule on laboratory developed tests. The meeting provided a crucial opportunity for attendees to learn more about what this rule means for their labs and patient care. Golden hopes that attendees will return home inspired and eager to implement what they've learned at this year's meeting in their work. He also looks forward to seeing what next year's meeting in Chicago from July 27-31 will bring.
In conclusion, ADLM 2024 was a resounding success with record-breaking attendance and groundbreaking advancements in diagnostic research and technology. The meeting provided a vital platform for laboratory medicine professionals to learn, network, and stay updated on the latest developments in their field.
Filed Under: Business
0 Comments
Latest on illi News
- Blue Sparrow Coffee named Best Matcha in Westword's Best of Denver 2026
- Ocean County College Introduces Pathways to Simplify the Student Journey and Strengthen Career Connections
- Kiko Nation Expands to Apple App Store, Achieving Full Mobile Deployment for Livestock Digital Registry Platform
- The Lawyers' Marketer Launches Claude AI Implementation Service for Law Firms
- Certified Trading Card Association and Collectors MD Launch Healthy Hobby Initiative
- Not a Moment, a Movement Fueled by Consistency and Driven by Purpose:
- Chicago: Mayor Brandon Johnson, Mayor's Office of Homelessness Release City's Five-Year Blueprint on Homelessness
- L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
- FinIQ Edu Launches High-Impact Workshop Vertical to Close the Workplace Benefits Gap—Drives 82% Surge in 401(k) Participation Intent
- HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
- Chicago: Mayor Brandon Johnson, Department of Planning and Development Announce Spring Purchase Opportunities for Vacant City Lots
- J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
- Digi 995 Launches Signature Logo Hoodie Blending Streetwear and Sci-Fi Identity
- Mayor Brandon Johnson, Superintendent Larry Snelling Celebrate Graduation of 248 New Chicago Police Officers
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
- Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
- IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
- AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
- Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)
- Mom Creators Coalition Launches with WaterWipes® as Official Founding Sponsor